Compound	Paclitaxel
NPACT-Id	NPACT00839
IUPAC	-
Synonyms	paclitaxel;TAXOL;Yewtaxan;Paxceed;Paxene;Taxol A;Abraxane;Plaxicel;Xorane;Onxol;LipoPac;Paclitaxel (Taxol);Anzatax;Epitaxol;Genaxol;Intaxel;Nanotaxel;Paclical;Pacligel;Paxoral
PubChem Id	36314
Class	Terpenoids
In-vitro anticancer activity	15 cancer cell lines
In-Vivo anticancer activity	No
Targets	MAPK1 \| PRKACA \| All \|
Properties	Physical Elemental Topological
InChi Key	RCINICONZNJXQF-MZXODVADSA-N
InChi	1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6
SMILES	O1[C@H]2[C@](OC(=O)C)([C@@H]3[C@@]([C@@H](O)C2)(C(=O)[C@H](OC(=O)C)C2=C([C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C[C@@](O)([C@H]3OC(=O)c3ccccc3)C2(C)C)C)C)C1
SMART	[H]O[C@@]([H])(C(=O)O[C@]1([H])C(=C2[C@@]([H])(OC(=O)C([H])([H])[H])C(=O)[C@]3(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[C@@]4([H])OC([H])([H])[C@@]4(OC(=O)C([H])([H])[H])[C@@]3([H])[C@]([H])(OC(=O)C3=C([H])C([H])=C([H])C([H])=C3[H])[C@](O[H])(C1([H])[H])[C@]2(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])[C@@]([H])(N([H])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1[H]
CAS No.	33069-62-4
Structure Download
Cross Refrence in other databases
	Super Natural	033069624
	CTD	D017239
	HIT	C0480
	NCI-60 GI₅₀ data	33069-62-4
Suppliers	ABI Chem, AKos Consulting & Solutions, Ambinter, MolPort, Sigma-Aldrich, Therapeutic Targets Database,
Drug-Likeliness Filters	Lipinski's rule of five	No
	Ghose filter	No
	Veber filter	No
	Muegge Filter	No
Similarity Search	Human metabolite database	FDA approved drugs

NPACT

Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase

Help

FAQs

Statistics

Tool

Contact